Report of Foreign Issuer (6-k)
April 13 2018 - 6:06AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
Report
of Foreign Private Issuer
Pursuant to Rule 13
A
-16
or 15
d
-16 of
The
Securities Exchange Act of 1934
For
the month of
April 2018
C
OMMISSION
F
ILE
N
umber
.
000-29338
CARDIOME
PHARMA CORP.
(Translation
of registrant’s name into English)
1441
Creekside Drive, 6th floor
Vancouver,
British Columbia, V6J 4S7, CANADA
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
DOCUMENTS INCLUDED AS PART OF THIS REPORT
Exhibit
|
|
Description
|
99.1
|
|
Information Circular
|
99.2
|
|
Form of Proxy
|
99.3
|
|
Voting Information Form
|
99.4
|
|
Financial Statement Request Form
|
99.5
|
|
Abridgment Certificate
|
Exhibits 99.1, 99.2, 99.3, 99.4, and 99.5 of t
his
report on Form
6-K are incorporated by reference into the Registrant’s registration statements on Form F-10
(No. 333-209606) and Form S-8 (Nos. 333-199091 and 333-199092) that have been filed with the Securities and
Exchange Commission.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
CARDIOME
PHARMA CORP.
|
|
(Registrant)
|
|
|
|
Date:
April 12, 2018
|
By:
|
/s/
Justin Renz
|
|
|
Name: Justin Renz
|
|
|
Title: Chief Financial Officer
|
Correvio Pharma (NASDAQ:CORV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Correvio Pharma (NASDAQ:CORV)
Historical Stock Chart
From Sep 2023 to Sep 2024